The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The high-density lipoprotein (HDL) cholesterol concentration is inversely related to the risk of coronary artery disease. The cholesteryl ester transfer protein (CETP) has a central role in the metabolism of this lipoprotein and may therefore alter the susceptibility to atherosclerosis. METHODS: The DNA of 807 men with angiographically documented coronary atherosclerosis was analyzed for the presence of a polymorphism in the gene coding for CETP. The presence of this DNA variation was referred to as B1, and its absence as B2. All patients participated in a cholesterol-lowering trial designed to induce the regression of coronary atherosclerosis and were randomly assigned to treatment with either pravastatin or placebo for two years. RESULTS: The B1 variant of the CETP gene was associated with both higher plasma CETP concentrations (mean [+/-SD], 2.29+/-0.62 microg per milliliter for the B1B1 genotype vs. 1.76+/-0.51 microg per milliliter for the B2B2 genotype) and lower HDL cholesterol concentrations (34+/-8 vs. 39+/-10 mg per deciliter). In addition, we observed a significant dose-dependent association between this marker and the progression of coronary atherosclerosis in the placebo group (decrease in mean luminal diameter: 0.14+/-0.21 mm for the B1B1 genotype, 0.10+/-0.20 mm for the B1B2 genotype, and 0.05+/-0.22 mm for the B2B2 genotype). This association was abolished by pravastatin. Pravastatin therapy slowed the progression of coronary atherosclerosis in B1B1 carriers but not in B2B2 carriers (representing 16 percent of the patients taking pravastatin). CONCLUSIONS: There is a significant relation between variation at the CETP gene locus and the progression of coronary atherosclerosis that is independent of plasma HDL cholesterol levels and the activities of lipolytic plasma enzymes. This common DNA variant appears to predict whether men with coronary artery disease will benefit from treatment with pravastatin to delay the progression of coronary atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,204
Jukema, J. W., Bruschke, A. V. G., van Boven, A. J., Reiber, J. H. C., Bal, E. T., Zwinderman, A. H., Jansen, H., Boerma, G. J. M., van Rappard, F. M., & Lie, K. I. (1995) · Circulation · doi:10.1161/01.cir.91.10.2528 · Cited by 842
Self-citationEffect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
MAAS Investigators (1994) · The Lancet · doi:10.1016/s0140-6736(94)92082-6 · Cited by 647
PLASMA LIPID TRANSFER PROTEINS
Tall, A. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.001315 · Cited by 639
Blankenhorn, D. H., Azen, S. P., Kramsch, D. M., Mack, W. J., Cashin-Hemphill, L., Hodis, H. N., DeBoer, L. W. V., Mahrer, P. R., Masteller, M. J., Vailas, L. I., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00002 · Cited by 637
Zhong, S., Sharp, D. S., Grove, J. S., Bruce, C., Yano, K., Curb, J. D., & Tall, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118751 · Cited by 583
Waters, D., Higginson, L., Gladstone, P., Kimball, B., Le May, M., Boccuzzi, S. J., & Lespérance, J. (1994) · Circulation · doi:10.1161/01.cir.89.3.959 · Cited by 499
Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
Marotti, K. R., Castle, C. K., Boyle, T. P., Lin, A. H., Murray, R. W., & Melchior, G. W. (1993) · Nature · doi:10.1038/364073a0 · Cited by 445
Agellon, L. B., Walsh, A., Hayek, T., Moulin, P., Jiang, X. C., Shelanski, S. A., Breslow, J. L., & Tall, A. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99088-5 · Cited by 298
Prognostic significance of progression of coronary atherosclerosis.
Waters, D., Craven, T. E., & Lespérance, J. (1993) · Circulation · doi:10.1161/01.cir.87.4.1067 · Cited by 277
Hayek, T., Masucci-Magoulas, L., Jiang, X., Walsh, A., Rubin, E., Breslow, J. L., & Tall, A. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118255 · Cited by 265
Reymer, P. W. A., Gagné, E., Groenemeyer, B. E., Zhang, H., Forsyth, I., Jansen, H., Seidell, J. C., Kromhout, D., Lie, K. E., Kastelein, J., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-28 · Cited by 239
Self-citationAzen, S. P., Mack, W. J., Cashin-Hemphill, L., LaBree, L., Shircore, A. M., Selzer, R. H., Blankenhorn, D. H., & Hodis, H. N. (1996) · Circulation · doi:10.1161/01.cir.93.1.34 · Cited by 215
McPherson, R., Mann, C. J., Tall, A. R., Hogue, M., Martin, L., Milne, R. W., & Marcel, Y. L. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.797 · Cited by 215
Self-citationKuivenhoven, J. A., de Knijff, P., Boer, J. M. A., Smalheer, H. A., Botma, G.-J., Seidell, J. C., Kastelein, J. J. P., & Pritchard, P. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.3.560 · Cited by 210
Self-citationPrognostic significance of progression of coronary atherosclerosis.
DWaters, ECraven, T., & JLespérance (1993) · Circulation · Cited by 198
Freeman, D. J., Griffin, B. A., Holmes, A. P., Lindsay, G. M., Gaffney, D., Packard, C. J., & Shepherd, J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.3.336 · Cited by 188
Changes in Sequential Coronary Arteriograms and Subsequent Coronary Events
Buchwald, H. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490110067031 · Cited by 168
Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins.
Quinet, E., Tall, A., Ramakrishnan, R., & Rudel, L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115169 · Cited by 162
Hannuksela, M. L., Liinamaa, J., Kesäniemi, Y. A., & Savolainen, M. J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90065-5 · Cited by 143
Groenemeijer, B. E., Hallman, M. D., Reymer, P. W. A., Gagné, E., Kuivenhoven, J. A., Bruin, T., Jansen, H., Lie, K. I., Bruschke, A. V. G., Boerwinkle, E., et al. (1997) · Circulation · doi:10.1161/01.cir.95.12.2628 · Cited by 137
Self-citationJukema, J. W., van Boven, A. J., Groenemeijer, B., Zwinderman, A. H., Reiber, J. H. C., Bruschke, A. V. G., Henneman, J. A., Molhoek, G. P., Bruin, T., Jansen, H., et al. (1996) · Circulation · doi:10.1161/01.cir.94.8.1913 · Cited by 123
Self-citationHayek, T., Chajek‐Shaul, T., Walsh, A., Agellon, L. B., Moulin, P., Tall, A. R., & Breslow, J. L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115887 · Cited by 121
Buchwald, H. (1992) · JAMA · doi:10.1001/jama.268.11.1429 · Cited by 87
Yen, F. T., Deckelbaum, R. J., Mann, C. J., Marcel, Y. L., Milne, R. W., & Tall, A. R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114112 · Cited by 84
Bu, X., Warden, C. H., Xia, Y.-R., Meester, C. D., Puppione, D. L., Teruya, S., Lokensgard, B., Daneshmand, S., Brown, J., Gray, R. J., et al. (1994) · Human Genetics · doi:10.1007/bf00201563 · Cited by 74
Guérin, M., Dolphin, P. J., Talussot, C., Gardette, J., Berthézène, F., & Chapman, M. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1359 · Cited by 70
Bhatnagar, D., Durrington, P. N., Channon, K. M., Prais, H., & Mackness, M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90220-o · Cited by 66
Cholesteryl ester transfer protein: friend or foe?
Fielding, C. J., & Havel, R. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118719 · Cited by 66
Cheung, M. C., Austin, M. A., Moulin, P., Wolf, A. C., Cryer, D., & Knopp, R. H. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90089-d · Cited by 64
Ahnadi, C.-E., Berthézène, F., & Ponsin, G. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90024-o · Cited by 54
F�ger, B., Luef, G. J., Ritsch, A., Schmidauer, C., Doblinger, A., Lechleitner, M., Aichner, F., & Patsch, J. R. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00192888 · Cited by 45
Jd, B., Lane, J. T., Stone, N. J., Ritter, M., & Subbaiah, P. V. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42635-5 · Cited by 30
Tamminen, M., Kakko, S., Kesäniemi, Y. A., & Savolainen, M. J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05833-9 · Cited by 20
Cholesterol-lowering and coronary atherosclerosis: Good news and bad news
Kreisberg, R. A. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00311-7 · Cited by 8
Cited by
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis
Barter, P. J., Brewer, H. B., Chapman, M. J., Hennekens, C. H., Rader, D. J., & Tall, A. R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054658.91146.64 · Cited by 870
Metadata
- Authors
- Kuivenhoven, J. A., Jukema, J. W., Zwinderman, A. H., de Knijff, P., McPherson, R., Bruschke, A. V. G., Lie, K. I., & Kastelein, J. J. P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1998-01-08
- Volume
- 338
- Issue
- 2
- Pages
- 86-93
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2339428433
- Cited by
- 625
- References
- 36
- FWCI
- 61.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.